Magotra, Ratna2019-09-252019-09-252011-03-102006-010975-5691http://hdl.handle.net/20.500.12424/176811"On September 19, 2005, the Bombay High Court asked the Central government to fix standards for drug-eluting cardiac stents. Till standards are developed, only four companies, with either US or European certification, are allowed to sell stents in Maharashtra. The High Court decision followed press reports that the Maharashtra state government’s JJ hospital had been using untested cardiac stents on its patients. It has been suggested that the controversy was created by competing stent manufacturing and distributing companies. In any case, it has raised a number of issues of concern to medical ethics, of both practice and research, in India."engWith permission of the license/copyright holderaccountabilitymultinational corporationsmedical ethicsBioethicsMedical ethicsHealth ethicsArticle